10-Year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb

Gene Therapy

Volumn 19, Issue 4, 2012, Pages 392-395

  Muona, K ^a   Makinen K ^a   Hedman, M ^a   Manninen, H ^a   Yla Herttuala S ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

follow up; peripheral arterial occlusive disease; safety; vascular endothelial growth factor

Indexed keywords

ADENOVIRUS VECTOR; LIPOSOME; RECOMBINANT VASCULOTROPIN;

ADENOVIRUS; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CANCER INCIDENCE; CATARACT; CLAUDICATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; GENE TRANSFER; HUMAN; INTERVIEW; LEG AMPUTATION; LEG ISCHEMIA; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NUCLEOTIDE SEQUENCE; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RHEUMATIC DISEASE; ULCER; VIRAL GENE THERAPY;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; AMPUTATION; CATHETERS; CAUSE OF DEATH; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; FOLLOW-UP STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENOVIRIDAE;

EID: 84859591761     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.109     Document Type: Article

References (33)

1. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123. (Pubitemid 28152883)
2. Tongers J, Roncalli J, Losordo D. Therapeutic angiogenesis for critical limb ischemia, microvascular therapies coming of age. Circulation 2008; 118: 9-16.
3. Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683. (Pubitemid 36667240)
4. Mäkinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002; 6: 127-133. (Pubitemid 36124280)
5. Amano H, Hackett NR, Kaner RJ, Whitlock P, Rosengart TK, Crystal RJ. Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy. Mol Ther 2005; 12: 715-724.
6. Wirth T, Hedman M, Mäkinen K, Manninen H, Immonen A, Vapalahti M et al. Safety profile of plasmid/lipsomes and virus vectors in clinical gene therapy. Curr Drug Saf 2006; 1: 253-257.
7. Kim H-J, Jang S, Park J-I, Buyn J, Kim D-I, Do S-Y. Vascular endothelial growth factor induced gene therapy in patients with peripheral arterial disease. Exp Mol Med 2004; 36: 336-344. (Pubitemid 39279529)
8. Noguchi P. Risks and benefits of gene therapy. New Engl J Med 2003; 348: 193-194. (Pubitemid 36077913)
9. Isner J, Vale P, Symes J, Losordo D. Assessement of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001; 89: 389-400. (Pubitemid 34132654)
10. Hacein-Bey-Abina S, Garrigue A,Wang GP, Soulier J, Lim A,Morillon E et al. Insertional ocogenesis in 4 patients after retrovitus-mediated gene therapy of SCID-X1. J Clin Invest 2008; 118: 3132-3142.
11. Dettweiler U, Simon P. Points to consider for ethics committees in human gene therapy trials. Bioethics 2001; 15: 491-500. (Pubitemid 33019869)
12. Gaffney MM, Hynes SO, Barry F, O'Brien T. Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol 2007; 152: 175-188. (Pubitemid 47517600)
13. Isner M, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998; 28: 964-975. (Pubitemid 28562700)
14. Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One Trial. J Am Coll Cardiol 2005; 45: 982-988. (Pubitemid 40432426)
15. Chen Y. Orthopedic applications of gene therapy. J Orthop Sci 2001; 6: 199-207. (Pubitemid 32367613)
16. Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker HE, Gyöngyösi M et al. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. Eurointervention 2011; 6: 813-818.
17. Hedman M, Muona K, Hedman A, Kivelä A, Syvänne M, Eränen J et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene Therapy 2009; 16: 629-634.
18. Fontaine R, Kim M, Kieny R. Die chirurgische Behandlung der peripheren Durchblutungsstörungen. Helv Chir Acta 1954; 21: 499-533.
19. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13-18. (Pubitemid 15153432)
20. Norgren L. Non-surgical treatment of critical limb ischaemia. Eur J Vasc Surg 1990; 4: 463-467.
21. Lepäntalo M, Mätzke S. Outcome of unreconstructed chronic crtical limb ischaemia. Eur J Vasc Endovasc Surg 1996; 11: 153-157. (Pubitemid 26120467)
22. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Atsuma J. Safety evaluation of clinical gene therapy using using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203-209. (Pubitemid 39014240)
23. Patel SR, Lee LY, Mack CA, Polce DR, El-Sawy T, Hackett NR et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther 1999; 10: 1331-1348. (Pubitemid 29267588)
24. Viita H, Kinnunen K, Eriksson E, Lähteenvuo J, Babu M, Kalesnykas G et al. Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes. Hum Gen Ther 2009; 20: 1679-1686.
25. Ylä-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701. (Pubitemid 36749218)
26. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Kivelä A, Hedman A et al. Adenoviral catheter-mediated intramyocardial VEGF-DNC gene transfer induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029-1035. (Pubitemid 38282857)
27. Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT et al. Increased revascularization efficacy after administration of adenovirus encoding VEGF121. Gene Therapy 2004; 11: 512-521. (Pubitemid 38443518)
28. Stewart DJ, Kutryk M, Fitchett D, Freeman M, Camack N, Su Y. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN TRIAL. Mol Ther 2009; 17: 1109-1115.
29. Hattan N, Chilian WM, Rocic P. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD. Basic Res Cardiol 2007; 102: 217-223. (Pubitemid 46564070)
30. Fujii H, Sun Z, Li SH, Wu J, Fazel S, Weisel RD et al. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc imaging 2009; 2: 880-882.
31. Tang J, Wang J, Zheng F, Kong X, Guo L, Yang J et al. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 2010; 339: 107-118.
32. Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal RS et al. Adenovirusmediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9: 1481-1486. (Pubitemid 28379087)
33. Laitinen M, Hartikainen J, Hiltunen MO, Eränen J, Kiviniemi M, Närvänen O et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11: 263-270. (Pubitemid 30080384)